
Creative Biolabs Launches Advanced Neuroscience Platforms to Address Growing Neurodegenerative Disease Research Needs
Creative Biolabs has introduced specialized neuroscience research platforms targeting Schwann cell function and microglia phagocytosis, providing critical tools for advancing research on Alzheimer's disease and other neurodegenerative conditions affecting over 55 million people worldwide.
Read full story

























